73 related articles for article (PubMed ID: 6232561)
1. [Behcet's disease with circulating anticoagulant].
Pedinielli FJ; Taillan B; Blanc AP; Medvedowsky JL; Juan-Vague I; Jauffret P
Presse Med; 1984 Apr; 13(18):1157. PubMed ID: 6232561
[No Abstract] [Full Text] [Related]
2. [Behçet's disease and lupus anticoagulant].
Torrelo Fernández A; España Alonso A; Medina Montalvo S; Ledo Pozueta A
Rev Clin Esp; 1990; 187(3):153. PubMed ID: 2126636
[No Abstract] [Full Text] [Related]
3. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
Kagawa H; Okubo S
Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic tendency in patients with Behçet's disease.
Balta I; Balta S; Demirkol S; Kucuk U
Acta Med Iran; 2015 Apr; 53(4):256. PubMed ID: 25871026
[No Abstract] [Full Text] [Related]
5. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
7. [Blood coagulation and fibrinolytic system in Behçet's disease (author's transl)].
Hamada T; Hosoi Y; Yoshimura R; Yamamoto S
Nihon Hifuka Gakkai Zasshi; 1978 Sep; 88(10):615-25. PubMed ID: 309522
[No Abstract] [Full Text] [Related]
8. [Behçet's disease with circulating anticoagulant...or anticoagulant in Behçet's disease?].
François M; Wattel A
Presse Med; 1984 Oct; 13(37):2271. PubMed ID: 6239182
[No Abstract] [Full Text] [Related]
9. [Behçet's disease with circulating anticoagulant... or anticoagulant in Behçet's disease?].
Pedinielli FJ; Blanc AP
Presse Med; 1984 Oct; 13(36):2212. PubMed ID: 6239164
[No Abstract] [Full Text] [Related]
10. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
[TBL] [Abstract][Full Text] [Related]
11. [The functioning of the fibrinolytic system in Behçet's syndrome].
Asbeck F; Meyer-Boernecke D; van de Loo J
Verh Dtsch Ges Inn Med; 1978; (84):1359-62. PubMed ID: 741967
[No Abstract] [Full Text] [Related]
12. [Lupus anticoagulant and Behçet's disease: increase of vascular risk?].
Bonnet F; Debruxelles S; Dubourguet L; Guérin V; Rambeloarisoa J; Morlat P; Baste JC; Beylot J
Rev Med Interne; 2004 Nov; 25(11):835-6. PubMed ID: 15501355
[No Abstract] [Full Text] [Related]
13. Abnormalities of T-cell subsets in Behçet's syndrome.
Lim SD; Haw CR; Kim NI; Fusaro RM
Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
[TBL] [Abstract][Full Text] [Related]
14. [Studies on blood coagulability activity in Behçet's disease (author's transl)].
Saito K; Higuchi M; Sugiura S
Nippon Ganka Gakkai Zasshi; 1976 Jan; 80(1):1-6. PubMed ID: 943906
[No Abstract] [Full Text] [Related]
15. Serum prolactin levels in Behçet's disease. Is there a relationship between Behcet's disease and prolactin as in other autoimmune diseases?
Avci A; Avci D
Acta Dermatovenerol Croat; 2013; 21(1):52-3. PubMed ID: 23683488
[No Abstract] [Full Text] [Related]
16. Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease.
Haznedaroğlu IC; Ozdemir O; Ozcebe O; Dündar SV; Kirazli S
Thromb Haemost; 1996 Jun; 75(6):974-5. PubMed ID: 8822597
[No Abstract] [Full Text] [Related]
17. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
[TBL] [Abstract][Full Text] [Related]
18. Coagulation and fibrinolytic activity in Behçet's disease.
Hampton KK; Chamberlain MA; Menon DK; Davies JA
Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
[TBL] [Abstract][Full Text] [Related]
19. Decreased fibrinolysis in Behçet's disease.
Chajek T; Aronowski E; Izak G
Thromb Diath Haemorrh; 1973 Jun; 29(3):610-8. PubMed ID: 4761829
[No Abstract] [Full Text] [Related]
20. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
